Medically Reviewed by Dr. Elena Rostova, MD, Board-Certified Dermatologist | Updated: April 2026
Miracle Touch UP Booster: Clinical Specifications & Efficacy
Miracle Touch UP is a professional-grade, bio-stimulatory dermal filler. It features polycaprolactone (PCL) microspheres suspended in a non-animal stabilized hyaluronic acid (HA) carrier gel. The formulation is engineered to induce neocollagenesis, restore dermal volume, and treat atrophic scarring through sustained polymer degradation.
Clinical Efficacy Metrics
+68% Collagen Synthesis
Type I and III collagen production increased significantly at week 12 post-treatment, confirmed via histological in-vivo biopsy.
+42% Dermal Elasticity
Elasticity and skin turgor improvements measured by cutometer following a standard protocol of 3 treatment sessions.
12-14 Month Longevity
Scaffold degradation timeline spans over 12 months, providing sustained structural support and continuous cellular activation.
Formula Composition & Packaging Specifications
Active Compounds
• 20% Polycaprolactone (PCL) Microspheres (25-50µm)
• 10mg/ml Cross-linked Hyaluronic Acid (HA)
• Pyroglutamic Acid (PCA)
• Essential Amino Acid Complex
Packaging Data
• Format: 5 sterile vials per box
• Volume: 2.0ml per vial (10ml total)
• Status: Medical-grade sterile packaging
• Storage: 2°C to 25°C (Do not freeze)
Administration Protocol
Target Layer: Deep dermis or superficial subcutaneous tissue.
Technique: Serial puncture or linear threading utilizing 30G or 32G micro-needles.
Dosage Parameters: 0.1ml to 0.2ml per injection point. Maximum 2.0ml per facial area per session.
Treatment Cycle: Standard protocol requires 3 sessions spaced 4 weeks apart. Maintenance session recommended at 6 months.
Safety Profile & Contraindications
Expected Adverse Events
• Transient erythema (redness)
• Localized edema (swelling) lasting 48-72 hours
• Mild ecchymosis (bruising) at injection sites
Note: Symptoms typically resolve spontaneously within 3 to 7 days post-treatment.
Absolute Contraindications
• Active cutaneous infections (e.g., Herpes Simplex, Acne lesions)
• Known hypersensitivity to PCL or HA components
• Pregnancy or lactation
• Autoimmune connective tissue diseases
Scientific References
1. Kim J, et al. (2022). “Neocollagenesis after injection of polycaprolactone microspheres: A histological study.” Journal of Clinical Dermatology, 45(3), 112-118.
2. Manufacturer Clinical Data (2023). “Efficacy and Safety of Miracle Touch UP in Facial Rejuvenation: A 12-Month Cohort Study.” Document ID: MT-23-CL01.
STRICTLY FOR PROFESSIONAL USE
Miracle Touch UP is a regulated aesthetic device. Sales and administration are restricted exclusively to licensed dermatologists, plastic surgeons, and certified medical aesthetic practitioners. Self-administration poses severe medical risks including infection, necrosis, and vascular occlusion.

Reviews
There are no reviews yet.